Braden Michael Leonard, a major owner of ProPhase Labs, recently acquired 12,500 shares of the company. The buys took place at prices ranging from $1.40 to $1.41 per share, on dates ranging from September 16 to September 18, 2014. Leonard now owns 1,907,500 shares of the company. Leonard operates out of Zionsville, IN. Some additional info was provided as follows:
Represents the purchase of shares in [ 38 ] separate transactions, ranging in price from $1.40 to $1.42, resulting in a weighted average sale price per share of $1.41. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Represents the purchase of shares i
n [ 2 ] separate transactions at $1.40. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017